(Q39161810)

English

Preclinical study of Ublituximab, a Glycoengineered anti-human CD20 antibody, in murine models of primary cerebral and intraocular B-cell lymphomas

scientific article published on May 2013

Statements

Preclinical study of Ublituximab, a Glycoengineered anti-human CD20 antibody, in murine models of primary cerebral and intraocular B-cell lymphomas (English)
0 references
0 references
0 references
Rym Ben Abdelwahed
Jérémie Cosette
Alexandra Jacquet
Bénédicte Fournès
Mélanie Gillard Bocquet
Valérie Touitou
Marie-Christine Naud

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit